A ‘landmark moment’ is being celebrated in the NHS as a first-of-its-kind therapy that can delay the onset of type 1 diabetes for up to three years will be made available.
The National Institute for Health and Care Excellence (Nice) has approved teplizumab, which the charity Diabetes UK said “marks the start of a new age of type 1 diabetes treatment”.